Blinatumomab in B-ALL: BiTE Construction, Mechanism, Resistance & Trials
Writer: Alisha G CSummaryBlinatumomab is a first-in-class bispecific T-cell engager (BiTE) antibody…
Understanding Antimicrobial Resistance in MRSA: Mechanisms, Challenges, and Emerging Insights
Introduction: Why MRSA Resistance MattersImagine a battlefield where humans deploy their strongest…
